Edition:
United Kingdom

CytomX Therapeutics Inc (CTMX.OQ)

CTMX.OQ on NASDAQ Stock Exchange Global Select Market

22.75USD
3:09pm GMT
Change (% chg)

$0.31 (+1.38%)
Prev Close
$22.44
Open
$22.53
Day's High
$22.75
Day's Low
$22.40
Volume
10,002
Avg. Vol
141,913
52-wk High
$24.50
52-wk Low
$10.44

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 8.75 -0.686
Mar '17 11.65 -0.226
FY 2016 Dec '16 6.27 -0.385
Sep '16 3.45 -0.404
Jun '16 3.09 -0.393
Mar '16 2.22 -0.444
FY 2015 Dec '15 1.99 -0.390
Sep '15 1.94 -0.412
Jun '15 2.04 -0.217
Mar '15 1.74 -0.219
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 7 10.10 15.00 0.60 9.20
Quarter Ending Mar-18 4 18.53 25.80 14.73 --
Year Ending Dec-17 7 55.74 61.00 45.20 24.00
Year Ending Dec-18 7 67.91 104.60 44.11 25.15
Earnings (per share)
Quarter Ending Dec-17 7 -0.43 -0.25 -0.70 -0.40
Quarter Ending Mar-18 4 -0.22 -0.01 -0.33 --
Year Ending Dec-17 7 -1.62 -1.43 -1.90 -1.75
Year Ending Dec-18 7 -1.53 -0.42 -2.69 -2.35
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.65 32.93
P/E High - Last 5 Yrs. -- 290.75 45.62
P/E Low - Last 5 Yrs. -- 93.66 24.34
Beta -- 0.85 0.88
Price to Sales (TTM) 26.31 100.67 5.40
Price to Book (MRQ) 15.16 13.50 5.38
Price to Tangible Book (MRQ) 16.00 13.43 6.78
Price to Cash Flow (TTM) -- 76.23 23.45
% Owned Institutions 76.32 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 182.87 433.84 9.00
Sales (TTM) vs TTM 1 Yr. Ago 225.95 75.03 5.38
Sales - 5 Yr. Growth Rate -- 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -74.65 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago -3.77 -- --
EPS - 5 Yr. Growth Rate -- 43.17 10.79
Capital Spending - 5 Yr. Growth Rate -- 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) 5.62 5.36 2.98
LT Debt to Equity (MRQ) 0.00 18.92 11.56
Total Debt to Equity (MRQ) 0.00 20.59 15.81
Interest Coverage (TTM) -- -112.49 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -203.90 -- --
EBITD - 5 Yr. Avg -- -261.11 15.24
Operating Margin (TTM) -209.53 -556.64 7.76
Operating Margin - 5 Yr. Avg. -- -279.29 10.75
Pre-Tax Margin (TTM) -206.33 -529.88 8.57
Pre-Tax Margin - 5 Yr. Avg. -- -279.02 11.17
Net Profit Margin (TTM) -206.33 -531.33 4.88
Net Profit Margin - 5 Yr. Avg. -- -282.20 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 386,295 25,314,503 864,673,321
Net Income/Employee (TTM) -797,026 3,332,048 101,717,508
Receivable Turnover (TTM) 103.37 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) 0.11 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -22.25 -0.78 11.00
Return on Assets - 5 Yr. Avg. -- -0.26 12.43
Return on Investment (TTM) -26.13 2.35 14.46
Return on Investment - 5 Yr. Avg. -- 2.98 16.28
Return on Equity (TTM) -81.04 2.95 16.05
Return on Equity - 5 Yr. Avg. -- 6.40 17.51
  1 Year 3 Year 5 Year
Sales % 95.06 156.83 --
EPS (TTM) % 66.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for CytomX Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 25.29 20.97 87 53
13 Week 32.88 26.41 86 61
26 Week 25.44 15.90 77 69
52 Week 39.97 18.64 74 46
YTD 95.63 71.81 87 50
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 78.71%
# of Holders: 154
Total Shares Held: 30,232,321
3 Mo. Net Change: 2,218,384
# New Positions: 28
# Closed Positions: 19
# Increased Positions: 84
# Reduced Positions: 48
# Net Buyers: 36
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.